MENU
VYGR
AS OF
Dec 24 closing price
Price
$4.07
Change
+$0.08 (+2.01%)
Capitalization
226.29M
74 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
VYGR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Voyager Therapeutics (VYGR) Ownership - Who owns Voyager Therapeutics?

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
226.29M
P/E Ratio
6.00
Total Cash
45.13M
Projected Growth
N/A
Total Debt
38.37M
Revenue
31.32M
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.54 USD as % of share price

Fundamentals

VYGR
Capitalization
226M
P/E Ratio
6.00
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
45.1M
Total Cash/Share
0.81
Total Debt
38.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.54%
Revenue
31.3M
ROE
N/A
Book Value
220M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
-2.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
6.19
Current Revenue Per Employee
77703.49
Dividends Per Share - Security
N/A
EBITDA
-136.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.50
Shares Held By Institutions
391M
Shares Outstanding - Current
55.6M
Total Liabilities
68.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-28.219
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VYGR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VYGR showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for VYGR
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com